Clinical Trials for Annias Immunotherapeutics

Explore 1 clinical trials worldwide

Showing 1-1 of 1 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Annias Immunotherapeutics

Clinical Trials (1)

NCT03299309
PEP-CMV in Recurrent MEdulloblastoma/Malignant Glioma
PHASE1Active, not recruiting
30 participants
Started: Jun 29, 2018 · Completed: Apr 30, 2026
3 conditions3 sponsors1 location